Nuclear Medicine

Introduction to PET/CT Imaging

<1 m.

How to Use the Case Viewer to Evaluate PET/CT Images in this Course

1 m.

What is PET/CT Imaging?

6 m.

Commonly Used Positron-emitting Radionuclides

1 m.

PET/CT Imaging Acquisition

3 m.

PET/CT Quality Control

4 m.

Quantification of Tracer Uptake

5 m.

Factors Impacting Quantification of Tracer Uptake

2 m.

Where to Start: Reading a PET/CT Study

8 m.

Case: Systematic Approach to Reading a PET/CT Study

8 m.

Case: Setting Up Your Imaging Display for a PET/CT Study

4 m.

PET/CT Report Example

1 m.

Introduction to FDG

3 m.

FDG: Patient Preparation

1 m.

FDG: Patterns of Muscle Uptake

5 m.

FDG: Patterns of Bone Marrow Uptake and the Effects of G-CSF

4 m.

FDG: Patterns of Bone Marrow Uptake and the Effects of Bone Marrow Disease

2 m.

Case: Normal Distribution of FDG Tracer

3 m.

Case: Abnormal Distribution of FDG (Hyperinsulinemia)

5 m.

Cases: Abnormal Distribution of FDG (Hyperinsulinemia, Rhabdomyolysis, Myositis)

1 m.

Overview of Common Pitfalls and Benign Lesions With FDG

<1 m.

Fractures on FDG PET/CT

1 m.

FDG Case: Brown Fat

4 m.

FDG Case: LHIAS

2 m.

FDG Case: Pleurodesis

2 m.

FDG Case: Metformin

2 m.

FDG Case: Aspiration Pneumonia

3 m.

FDG Case: Osteoarthritis

2 m.

FDG Case: Metallic Artifact

2 m.

Role of FDG PET/CT Imaging in Lymphoma: Classification and Staging

6 m.

Role of FDG PET/CT Imaging in Lymphoma: Response to Therapy

2 m.

Role of FDG PET/CT Imaging in Lymphoma: Follow-up Reports

2 m.

FDG Case: Hodgkin's Lymphoma, Initial Presentation

8 m.

FDG Case: Hodgkin's Lymphoma, Follow-up

5 m.

FDG Case: DLBCL, Initial Presentation

4 m.

FDG Case: DLBCL, Follow-up

4 m.

FDG Case: Multiple Myeloma

6 m.

Role of FDG PET/CT Imaging in Solitary Pulmonary Nodules and Lung Cancer

5 m.

FDG Case: Solitary Pulmonary Nodule

1 m.

FDG Case: Solitary Pulmonary Nodule With Positive Lymph Nodes

4 m.

FDG Case: Lung Cancer Delineation

2 m.

FDG Case: Lung Cancer Staging

1 m.

FDG Case: Squamous Cell Carcinoma

4 m.

Role of FDG PET/CT Imaging in Brain Tumors

7 m.

FDG Case: Brain Metastasis

3 m.

FDG Case: Breast Cancer Staging

3 m.

FDG Case: Breast Cancer Restaging and Treatment Response

5 m.

Role of FDG PET/CT Imaging in Immunotherapy: Basic Concepts

3 m.

Role of FDG PET/CT Imaging in Detecting Adverse Effects of Immunotherapy

8 m.

FDG Case: Response to Therapy and Adverse Events in Patient With Melanoma

6 m.

Introduction to DOTATATE

3 m.

DOTATATE: Patient Preparation

<1 m.

Case: Normal Distribution of DOTATATE Tracer

4 m.

DOTATATE: Common Pitfalls and Benign Lesions

<1 m.

DOTATATE Case: Meningioma

2 m.

DOTATATE Case: Inflammation

1 m.

DOTATATE Case: Prostatitis

2 m.

Role of PET/CT Imaging in Neuroendocrine Tumors

9 m.

DOTATATE Case: Gastric NET

2 m.

DOTATATE Case: Ileal NET

3 m.

DOTATATE Case: Pancreatic NET

3 m.

DOTATATE Case: Lung Carcinoid

3 m.

DOTATATE Case: Paraganglioma

1 m.

Introduction to PSMA

2 m.

PSMA: Patient Preparation

1 m.

Case: Normal Distribution of PSMA Tracer

2 m.

Common Pitfalls and Other Malignancies to Consider With PSMA

3 m.

Role of PSMA PET/CT In Prostate Cancer

8 m.

PSMA Case: Initial Staging of Prostate Cancer

2 m.

PSMA Case: Initial Staging, High Risk Prostate Cancer

3 m.

PSMA Case: Biochemical Recurrence in Prostate Cancer

5 m.

PSMA Case: Prostatectomy and Biochemical Recurrence

4 m.

Prostate-Specific Membrane Antigen (PSMA) PET - Interpretation and Applications

43 m.

Evaluation of Pulmonary Nodules and Lung Cancers (CT & PET/CT)

50 m.

Molecular PET in Head and Neck Oncology

42 m.

Watch this case review for free!

4 m.

Dementia Introduction

2 m.

CT vs MRI Imaging of Dementia

1 m.

Quantitative Volumetric Imaging of Dementia

4 m.

PET Imaging of Dementia (FDG, Amyloid, Tau)

2 m.

Alzheimer’s Disease Overview

9 m.

Dementia Imaging Case Review Introduction

1 m.

Alzheimer's Disease plus Cerebral Amyloid Angiopathy (CAA)

7 m.

Alzheimer’s Disease in 86 yo with Memory Loss

7 m.

Alzheimer’s Disease in 73 yo with Memory Loss

2 m.

Alzheimer’s Disease in 72 yo with Memory Loss

5 m.

Vascular Dementia in 81 yo with Sudden Onset Memory Loss

3 m.

Vascular Dementia, Alzheimer's, and Amyloid Angiopathy

5 m.

Dementia with Lewy Bodies (DLB) in 73 yo

9 m.

Frontotemporal Dementia (FTD) in 74 yo patient

4 m.

Logopenic Progressive Aphasia (LPA) in 55 yo

<1 m.

Logopenic Progressive Aphasia (LPA) in 48 yo

<1 m.

Traumatic Brain Injury and Encephalopathy

4 m.

Cerebral Amyloid Angiopathy with Inflammation (CAARI)

2 m.

Normal Pressure Hydrocephalus (NPH) with Alzheimer's Disease

9 m.

Overview of Approved DMT for Alzheimer's Disease

1 m.

Aducanumab

3 m.

Lecanemab

1 m.

Donanemab

<1 m.

Amyloid Related Imaging Abnormalities (ARIA)

6 m.

ARIA Case Review

4 m.

ARIA Mimics and Pitfalls

4 m.

ARIA's Impact on Imaging Facilities

8 m.

Dementia Summary

<1 m.

Introduction to PET Imaging of the Brain, Dr. Sally Ayesa (12-10-24)

59 m.

A Deep Dive Into PSMA PET Interpretation: State of the Art, Dr. Dimitrios Priftakis (5-30-24)

1 h.

Introduction to Reading Oncology PET/CT, Dr. Lacey J. McIntosh (1-17-24)

1 h.

Current Radiopharmaceutical Theranostic Applications in Nuclear Medicine, Dr. Steven Rowe (10-19-23)

1 h.

Critical Updates in the Dynamic Landscape of Alzheimer's Disease & Dementia Imaging, Dr. Suzie Bash (8-10-23)

1 h.

Prostate-Specific Membrane Antigen (PSMA) PET - Interpretation and Applications, Steven P. Rowe (7-20-23)

1 h.

PET-CT in Abdominal Pathologies, Sikandar Shaikh, DMRD, DNB, MNAMS, FICR, EDiR, 05/12/22

54 m.

Molecular PET in Head and Neck Oncology, Dr. Elcin Zan, (1/13/22)

47 m.

Somatostatin-Receptor Targeted PET/MR and PET/CT, Dr. Jana Ivanidze (06/23/2021)

49 m.

Evolving Updates in PET Molecular Imaging, Dr. Arif Sheikh (06/21/2021)

57 m.

Evaluation of Pulmonary Nodules and Lung Cancers with a Focus on Integrated Approach with CT and PET/CT, Dr. Lacey McIntosh (5/12/21)

1 h.

​MSK PET-CT, Dr. Sikandar Shaikh (11-27-20)

59 m.

Post treatment imaging in Head and Neck Cancer, Dr. Supreeta Arya (9-3-20)

49 m.

PET-CT of Neurologic Disorders, Dr. Sikandar Shaikh (9-2-20)

1 h.

PET-CT of Infection and Inflammation, Dr. Sikandar Shaikh (7-24-20)

1 h.

Nuclear Medicine for Common GI Pathologies, ​Dr. Nadine Mallak (7-17-20)

1 h.

PET Imaging of Oncologic Diseases, Dr. Sikandar Shaikh (6-26-20)

1 h.

Nuclear Medicine Hepatobiliary Imaging, Dr. Darlene Metter (5-20-20)

1 h.